NanoBio nabs $6M vax grant

NanoBio, a promising spinoff from the University of Michigan, nabbed a $6 million grant from the Gates Foundation for its work on a new nasal spray vaccine. NanoBio has been using its cutting edge nanoemulsion technology for a number of development programs. Gates' money will be spent in pursuit of a new treatment for RSV. Story

Suggested Articles

Denali is partnering with Biogen on its Parkinson's disease program, netting a $560 million upfront fee and a $465 million investment.

In the first half of 2020, the regenerative medicine sector raised $10.7 billion, more than the total it raised in 2019.

The trial linked RG6346 to reductions in hepatitis B surface antigen that suggest the RNAi therapy can hold its own against drugs from J&J and Vir.